首页> 外文期刊>North American Journal of Medical Sciences >Chlamydophila Pneumoniae Infection and Cardiovascular Disease
【24h】

Chlamydophila Pneumoniae Infection and Cardiovascular Disease

机译:肺炎衣原体感染和心血管疾病

获取原文
           

摘要

Atherosclerosis is a multifactorial vascular inflammatory process; however, the inciting cause for inflammation remains unclear. Two decades ago, Chlamydophila pneumoniae (formerly Chlamydia pneumoniae) infection was proposed as a putative etiologic agent. We performed a PubMed search using the keywords Chlamydia and atherosclerosis in a Boolean query to identify published studies on C. pneumoniae and its role in atherogenesis, and to understand research interest in this topic. We found 1,652 published articles on this topic between 1991 and 2011. We analyzed relevant published studies and found various serological, molecular, and animal modeling studies in the early period. Encouraged by positive results from these studies, more than a dozen antibiotic clinical-trials were subsequently conducted, which did not find clinical benefits of anti-Chlamydophila drug therapy. While many researchers believe that the organism is still important, negative clinical trials had a similar impact on overall research interest. With many novel mechanisms identified for atherogenesis, there is a need for newer paradigms in Chlamydophila-atherosclerosis research.Keywords: Atherosclerosis, Chlamydophila pneumonia, Cardiovascular disease, Infection
机译:动脉粥样硬化是一个多因素的血管炎性过程。然而,炎症的诱因仍不清楚。二十年前,有人提出将肺炎衣原体(以前称为肺炎衣原体)感染作为一种病因。我们在布尔查询中使用关键词衣原体和动脉粥样硬化进行了PubMed搜索,以鉴定已发表的关于肺炎衣原体及其在动脉粥样硬化中的作用的研究,并了解对此主题的研究兴趣。在1991年至2011年之间,我们发现了1,652篇关于该主题的文章。我们分析了相关的已发表研究,并在早期发现了各种血清学,分子和动物模型研究。在这些研究的积极结果的鼓舞下,随后进行了十多次抗生素临床试验,未发现抗衣原体药物疗法的临床益处。尽管许多研究人员认为这种生物仍然很重要,但阴性临床试验对总体研究兴趣也有类似的影响。随着许多新的动脉粥样硬化形成机制的发现,在嗜衣藻-动脉粥样硬化研究中需要一种较新的范式。关键词:动脉粥样硬化,衣原体肺炎,心血管疾病,感染

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号